β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin.
Giuseppe DanieleAndrea TuraAlex BrocchiAlessandro SabaBeatrice CampiVeronica Sancho-BornezAngela DardanoStephano Del PratoPublished in: Diabetes care (2024)
SAXA+DAPA provided superior glycemic control compared with DAPA or SAXA, with improved β-cell function, insulin sensitivity, GLP-1 availability, and glucose clearance.